Joinn Laboratories (China) Co Ltd

603127

Company Profile

  • Business description

    Joinn Laboratories (China) Co Ltd is a non-clinical contract research organization(CRO) focused on drug safety assessment. It operates in three segments: Non-clinical studies services include drug safety assessment, drug metabolism & pharmacokinetics (DMPK) studies, & pharmacology & efficacy studies; Clinical trial & related services segment provides early-stage services such as clinical CRO services, co-managed phase I clinical research units, & bioanalytical services, and: Sales of research models engages in the design, production, breeding, & sales of research models, currently including non-human primates and rodents. The majority is from the Non-Clinical studies services. Its geographical segments are China, the United States, and Other countries, of which the majority is from China.

  • Contact

    A5 Rongjing East Street
    Beijing Economic-Technological Development Area
    Beijing100176
    CHN

    T: +86 1067869966

    https://www.joinnlabs.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Diagnostics & Research

    Fiscal Year End

    31 December 2025

    Employees

    2,652

Stocks News & Analysis

stocks

Alibaba fair value increases by 49%

Stronger-than-expected AI demand internationally and domestically.
stocks

Our fair value on ASX share falls by half

Downgrading our estimates due to lower growth.
stocks

A 5-Star US stock to buy with a near-5% yield

Undervalued by 23%, this cheap dividend stock is a top pick in its sector.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,164.609.200.10%
CAC 407,880.8710.190.13%
DAX 4023,745.065.590.02%
Dow JONES (US)46,316.0768.780.15%
FTSE 1009,299.8415.010.16%
HKSE26,622.88494.681.89%
NASDAQ22,591.15107.090.48%
Nikkei 22544,910.57133.18-0.30%
NZX 50 Index13,157.6825.120.19%
S&P 5006,661.2117.510.26%
S&P/ASX 2008,880.4011.100.13%
SSE Composite Index3,862.5334.430.90%

Market Movers